Core Viewpoint - Moolec Science SA has announced a share consolidation with a final ratio of 15-for-1, effective January 5, 2026, to comply with Nasdaq listing requirements [1][4]. Share Consolidation Details - The share consolidation will reduce the number of issued and outstanding ordinary shares from 10,891,761 to approximately 726,118 shares [2]. - No fractional shares will be issued; any resulting fractional shares will be rounded up to the nearest whole share, ensuring no dilutive effect on shareholders [3]. Compliance and Trading Information - The consolidation aims to regain compliance with Nasdaq's minimum bid price requirement of U.S.$1.00 per share, as per Nasdaq Listing Rule 5550(a)(2) [4]. - The new shares will be admitted to trading on the Nasdaq Capital Market under CUSIP number G6223S 125 starting January 5, 2026 [4]. Company Overview - Moolec Science is focused on producing animal proteins and nutritional oils in plants, utilizing molecular farming and precision fermentation [6]. - The company has a diversified pipeline that includes alternative proteins, bioactive compounds, nutritional oils, and biological inputs for regenerative agriculture [6]. - Moolec holds over 118 granted and pending patents across multiple technology platforms, indicating a strong intellectual property portfolio [6].